Inhibikase Therapeutics, Inc. Quarterly Operating Lease, Liability, Noncurrent in USD from Q3 2022 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.
Summary
Inhibikase Therapeutics, Inc. quarterly Operating Lease, Liability, Noncurrent history and growth rate from Q3 2022 to Q2 2024.
  • Inhibikase Therapeutics, Inc. Operating Lease, Liability, Noncurrent for the quarter ending June 30, 2024 was $25.6K, a 82.9% decline year-over-year.
Operating Lease, Liability, Noncurrent, Quarterly (USD)
Operating Lease, Liability, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $25.6K -$124K -82.9% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $58.3K -$120K -67.3% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $90.1K -$115K -56.1% Dec 31, 2023 10-K 2024-03-27
Q3 2023 $121K -$111K -47.8% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $150K Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $178K Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $205K Dec 31, 2022 10-K 2023-03-31
Q3 2022 $232K Sep 30, 2022 10-Q 2022-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.